Zahra Beigzadeh

Dr. Zahra Beigzadeh


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Public Health
Verified
Journal Article
Closed access
BPB. Pourhassan
B. Pourhassan
AMA. Meysamie
A. Meysamie
SAS. Alizadeh
S. Alizadeh
AHA. Habibian
A. Habibian
ZBZahra Beigzadeh
Zahra Beigzadeh

27 September 2022 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
BPBahman Pourhassan
Bahman Pourhassan
RPReza Pourbabaki
Reza Pourbabaki
FOFariborz Omidi
Fariborz Omidi
SKSaba Kalantary
Saba Kalantary
ZBZahra Beigzadeh
Zahra Beigzadeh
Prostate Cancer (PCa) is the second most common hormone-sensitive neoplasm among men and the fifth cause of death due to malignancy in developed countries. Moreover, studies have shown the links between polychlorinated biphenyls (PCBs) and hormone-related cancers such as prostate cancer. Hence, we conducted a systematic review and meta-analysis to evaluate the potential relationship between the PCBs and developing PCa. In this meta-analysis study, the relevant databases such as Web of Science, PubMed, and Scopus were studied for English research. The Newcastle–Ottawa Scale was applied to evaluate the quality of the selected publications. The GRADE method was used to assess the risk of bias studies. After reviewing the relevant studies, a cohort and seven case–control studies entered the meta-analysis. These articles were published during 2003–2021 with 2989 participants and 1212 PCa cases. The heterogeneity among the studies was significant ( p = 0.001, I2 = 70.61). Using a random-effects model, the association between the serum and plasma levels of PCBs and the risk of PCa was not shown to be significant (OR = 1.12; 95% CI: 0.90–1.39). The results of Egger’s test showed no trace of publication bias in the studies (P of bias = 0.573). This systematic review and meta-analysis was presented based on relatively strong evidence and has confirmed negatively significant associations between PCa risk and some PCBs congeners (PCB 44, 52, and 101). This study does not provide strong evidence that total PCB exposure is a risk factor for PCa development in humans.